In aggressive childhood cancer, neuroblastoma, NDRG1 is considered to be a tumor suppressor, with its low expression being significantly associated with prognostic factors such as primary tumor size, MYCN amplification, and poor prognosis (57). Here, MYCN is linked to neoplasm.